These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U. Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292 [Abstract] [Full Text] [Related]
5. [The Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists--comments on the current therapy for neovascular AMD]. Pauleikhoff D, Bornfeld N, Gabel VP, Holz F, Roider H, German Ophthalmological Society, Retinological Society, Professional Association of Ophthalmologists. Klin Monbl Augenheilkd; 2005 May; 222(5):381-8. PubMed ID: 15912454 [Abstract] [Full Text] [Related]
6. Combined treatment modalities for age related macular degeneration. Das RA, Romano A, Chiosi F, Menzione M, Rinaldi M. Curr Drug Targets; 2011 Feb; 12(2):182-9. PubMed ID: 20887244 [Abstract] [Full Text] [Related]